期刊文献+

新生儿多脏器型假性醛固酮减少症Ⅰ型

Neonatal systemic pseudohypoaldosteronism type I
下载PDF
导出
摘要 患儿男,生后18d,因发现反复血钾升高10余天入院。患儿存在拒奶、呼吸困难,血气分析提示反复高钾血症、低钠血症和代谢性酸中毒,肾上腺皮质激素替代治疗无效。辅助检查提示醛固酮水平明显升高,家系全外显子组测序显示患儿存在SCNN1A基因复合杂合变异,变异来自父亲和母亲,患儿明确诊断为新生儿多脏器型假性醛固酮减少症Ⅰ型。通过给予降钾树脂和补充钠盐治疗,患儿电解质水平保持平稳,达临床痊愈出院。该文对婴儿失盐综合征的鉴别诊断进行重点描述,以及介绍新生儿多脏器型假性醛固酮减少症Ⅰ型的多学科诊疗。 An 18-day-old male infant was admitted to the hospital due to recurrent hyperkalemia for more than 10 days.The neonate had milk refusal and dyspnea.The blood gas analysis revealed recurrent hyperkalemia,hyponatremia and metabolic acidosis.Adrenocortical hormone replacement therapy was ineffective.Additional tests showed a significant increase in aldosterone levels.Family whole exome sequencing revealed that the infant had compound heterozygous in the SCNNIA gene,inherited from both parents.The infant was diagnosed with neonatal systemic pseudohypoaldosteronism type I.The infant's electrolyte levels were stabilized through treatment with sodium polystyrene sulfonate and sodium supplement.The infant was discharged upon clinical recovery.This study provides a focused description of differential diagnosis of salt-losing syndrome in infants and introduces the multidisciplinary management of neonatal systemic pseudohypoaldosteronism type I.
作者 曹芯诚 陈园园 张可 张迅捷 杨琳 李志华 CAO Xin-Cheng;CHEN Yuan-Yuan;ZHANG Ke;ZHANG Xun-Jie;YANG Lin;LI Zhi-Hua(Department of Neonatology,Children's Hospital of Fudan University/National Children's Medical Center,Shanghai 201102,China)
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2023年第7期774-778,共5页 Chinese Journal of Contemporary Pediatrics
关键词 假性醛固酮减少症 高钾血症 低钠血症 新生儿 Pseudohypoaldosteronism Hyperkalemia Hyponatremia Neonate
  • 相关文献

参考文献2

二级参考文献22

  • 1Zennaro MC, Hubert EL, Fernandes-Rosa FL. Aldosterone re- sistance: structural and functional considerations and new per- spectives [ J ]. Mol Cell Endocrinol, 2012,350 (2) : 206-215.
  • 2Krone N, Arlt W. Genetics of congenital adrenal hyperpla- sia [J]. Best Pract Res Clin Endocrinol Metab, 2009, 23 (2) : 181-192.
  • 3White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency [J ]. Endocr Rev, 2000,21 (2) : 245- 291.
  • 4White PC, Grossberger D, Onufer BJ, et al. Two genes encod- ing steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man [J]. Proc Natl Acad Sci USA, 1985,82(4) : 1089-1093.
  • 5Mendes C, Vaz Matos I, Ribeiro L, et al. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: genotype-phe- notype correlation [ J ]. Acta Med Port, 2015,28 ( 1 ) : 56-62.
  • 6Higashi Y, Tanae A, Inoue H, et al. Aberrant splicing and mis- sense mutations cause steroid 21-hydroxylase [P-450 (C21)] deficiency in humans: possible gene conversion products [J]. Proc Natl Acad Sci USA, 1988 , 85 (20) :7486-7490.
  • 7Speiser PW, Dupont J, Zhu D. Disease expression and molecu- lar genotype in congenital adrenal hyperplasia due to 21-hydrox- ylase deficiency [ J ]. J Clin Invest, 1992,90(2) :584-595.
  • 8Niakan KK, McCabe ERB. DAX-1 origin, function, and novel role[J].Mol GenetMetab,2005,86(1):70-83.
  • 9SekiguchiY,HaraY,MatsuokaH, et al. Sibling cases of Addi- son' s disease caused by DAX- 1 gene mutations [J].Intern Med, 2007,46(1):35-39.
  • 10Fujieda K, Tajima T. Molecular basis of adrenal insufficien- cy[J]. Pediatr Res ,2005,57(5Pt2) :62-69.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部